Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.

Moreau P, Attal M, Hulin C, Arnulf B, Belhadj K, Benboubker L, Béné MC, Broijl A, Caillon H, Caillot D, Corre J, Delforge M, Dejoie T, Doyen C, Facon T, Sonntag C, Fontan J, Garderet L, Jie KS, Karlin L, Kuhnowski F, Lambert J, Leleu X, Lenain P, Macro M, Mathiot C, Orsini-Piocelle F, Perrot A, Stoppa AM, van de Donk NW, Wuilleme S, Zweegman S, Kolb B, Touzeau C, Roussel M, Tiab M, Marolleau JP, Meuleman N, Vekemans MC, Westerman M, Klein SK, Levin MD, Fermand JP, Escoffre-Barbe M, Eveillard JR, Garidi R, Ahmadi T, Zhuang S, Chiu C, Pei L, de Boer C, Smith E, Deraedt W, Kampfenkel T, Schecter J, Vermeulen J, Avet-Loiseau H, Sonneveld P.

Lancet. 2019 Jun 3. pii: S0140-6736(19)31240-1. doi: 10.1016/S0140-6736(19)31240-1. [Epub ahead of print] Erratum in: Lancet. 2019 Jun 14;:.

PMID:
31171419
2.

Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).

Laribi K, Poulain S, Willems L, Merabet F, Le Calloch R, Eveillard JR, Herbaux C, Roos-Weil D, Chaoui D, Roussel X, Tricot S, Dupuis J, Dartigeas C, Bareau B, Bene MC, Baugier de Materre A, Leblond V.

Br J Haematol. 2019 Jul;186(1):146-149. doi: 10.1111/bjh.15718. Epub 2018 Dec 12. No abstract available.

PMID:
30548257
3.

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma.

Garderet L, Kuhnowski F, Berge B, Roussel M, Escoffre-Barbe M, Lafon I, Facon T, Leleu X, Karlin L, Perrot A, Moreau P, Marit G, Stoppa AM, Royer B, Chaleteix C, Tiab M, Araujo C, Lenain P, Macro M, Voog E, Benboubker L, Allangba O, Jourdan E, Orsini-Piocelle F, Brechignac S, Eveillard JR, Belhadj K, Wetterwald M, Pegourie B, Jaccard A, Eisenmann JC, Glaisner S, Mohty M, Hulin C, Loiseau HA, Mathiot C, Attal M.

Blood. 2018 Dec 13;132(24):2555-2563. doi: 10.1182/blood-2018-07-863829. Epub 2018 Oct 3.

PMID:
30282798
4.

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.

Perrot A, Lauwers-Cances V, Corre J, Robillard N, Hulin C, Chretien ML, Dejoie T, Maheo S, Stoppa AM, Pegourie B, Karlin L, Garderet L, Arnulf B, Doyen C, Meuleman N, Royer B, Eveillard JR, Benboubker L, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Kolb B, Fohrer C, Mohty M, Macro M, Richardson PG, Carlton V, Moorhead M, Willis T, Faham M, Anderson KC, Harousseau JL, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H, Munshi N.

Blood. 2018 Dec 6;132(23):2456-2464. doi: 10.1182/blood-2018-06-858613. Epub 2018 Sep 24.

PMID:
30249784
5.

Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study).

Le Calloch R, Lacut K, Le Gall-Ianotto C, Nowak E, Abiven M, Tempescul A, Dalbies F, Eveillard JR, Ugo V, Giraudier S, Guillerm G, Lippert E, Berthou C, Ianotto JC.

Haematologica. 2018 Apr;103(4):607-613. doi: 10.3324/haematol.2017.180448. Epub 2017 Dec 15.

6.

Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study.

Moreau P, Attal M, Caillot D, Macro M, Karlin L, Garderet L, Facon T, Benboubker L, Escoffre-Barbe M, Stoppa AM, Laribi K, Hulin C, Perrot A, Marit G, Eveillard JR, Caillon F, Bodet-Milin C, Pegourie B, Dorvaux V, Chaleteix C, Anderson K, Richardson P, Munshi NC, Avet-Loiseau H, Gaultier A, Nguyen JM, Dupas B, Frampas E, Kraeber-Bodere F.

J Clin Oncol. 2017 Sep 1;35(25):2911-2918. doi: 10.1200/JCO.2017.72.2975. Epub 2017 Jul 7.

7.

The presence of monoclonal gammopathy in Ph-negative myeloproliferative neoplasms is associated with a detrimental effect on outcomes.

Le Clech L, Sakka M, Meskar A, Kerspern H, Eveillard JR, Berthou C, Buors C, Lippert E, Guillerm G, Quintin-Roué I, Carré JL, Ianotto JC.

Leuk Lymphoma. 2017 Nov;58(11):2582-2587. doi: 10.1080/10428194.2017.1312380. Epub 2017 May 9.

PMID:
28482711
8.

[Multiple myeloma and venous thrombosis. Which thromboprophylaxis should be given?].

de Moreuil C, Ianotto JC, Eveillard JR, Carrier M, Delluc A.

Rev Med Interne. 2016 Jul;37(7):473-9. doi: 10.1016/j.revmed.2015.12.025. Epub 2016 Jan 28. French.

PMID:
26833146
9.

MLL partner genes in secondary acute lymphoblastic leukemia: report of a new partner PRRC1 and review of the literature.

Douet-Guilbert N, Eveillard JR, Meyer C, Ugo V, Le Bris MJ, Basinko A, Morel F, Marschalek R, De Braekeleer M.

Leuk Res. 2014 Nov;38(11):1316-9. doi: 10.1016/j.leukres.2014.08.011. Epub 2014 Aug 29. Review.

PMID:
25205603
10.

Dissociated evolution of a multifocal primary CNS lymphoma.

Bagacean C, Zdrenghea M, Popescu C, Quintin-Roue I, Ianotto JC, Eveillard JR, Berthou C, Tempescul A.

J BUON. 2013 Oct-Dec;18(4):1098. No abstract available.

11.

Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients.

Douet-Guilbert N, De Braekeleer E, Basinko A, Herry A, Gueganic N, Bovo C, Trillet K, Dos Santos A, Le Bris MJ, Morel F, Eveillard JR, Berthou C, De Braekeleer M.

Leukemia. 2012 Jul;26(7):1695-7. doi: 10.1038/leu.2012.9. Epub 2012 Jan 17. No abstract available.

PMID:
22290067
12.

Imatinib mesylate induces massive and nonspecific aminoaciduria in CML patients.

Ianotto JC, Tempescul A, Amet Y, Grall P, Dalbies F, Eveillard JR, Guillerm G, Berthou C.

Am J Hematol. 2012 Apr;87(4):437-9. doi: 10.1002/ajh.23113. Epub 2012 Jan 28. No abstract available.

13.

Experience (1 year) of G-CSF biosimilars in PBSCT for lymphoma and myeloma patients.

Ianotto JC, Tempescul A, Yan X, Delepine P, Le Calloch R, Hardy E, Eveillard JR, Mugnier N, Berthou C, Guillerm G.

Bone Marrow Transplant. 2012 Jun;47(6):874-6. doi: 10.1038/bmt.2011.189. Epub 2011 Sep 26. No abstract available.

PMID:
21946380
14.

Isolated 5p isochromosome in myelodysplastic syndrome: report of the first case.

Douet-Guilbert N, Basinko A, De Braekeleer E, Guéganic N, Bovo C, Le Bris MJ, Morel F, Eveillard JR, Berthou C, Herry A, De Braekeleer M.

Leuk Res. 2011 Nov;35(11):e193-7. doi: 10.1016/j.leukres.2011.07.008. Epub 2011 Jul 30. No abstract available.

PMID:
21803421
15.

Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience.

de Guibert S, Peffault de Latour R, Varoqueaux N, Labussière H, Rio B, Jaulmes D, Eveillard JR, Dulucq S, Stoppa AM, Bouscary D, Girodon F, Bonnotte B, Laskri D, Socié G, Lamy T.

Haematologica. 2011 Sep;96(9):1276-83. doi: 10.3324/haematol.2010.037531. Epub 2011 May 23.

16.

Delayed G-CSF stimulation after PBSCT does not seem to modify the biological parameters of bone marrow recovery.

Ianotto JC, Tempescul A, Delepine P, Guillerm G, Hardy E, Eveillard JR, Berthou C.

Am J Hematol. 2011 Apr;86(4):351-2. doi: 10.1002/ajh.21991.

17.

Three rearrangements of chromosome 5 in a patient with myelodysplastic syndrome: an atypical deletion 5q, a complex intrachromosomal rearrangement of chromosome 5, and a paracentric inversion of chromosome 5.

Douet-Guilbert N, Basinko A, Eveillard JR, Morel F, Le Bris MJ, Guéganic N, Bovo C, Herry A, Berthou C, De Braekeleer M.

Cancer Genet Cytogenet. 2010 Dec;203(2):303-8. doi: 10.1016/j.cancergencyto.2010.07.129.

PMID:
21156249
18.

ESHAP chemotherapy regimen associated to lenalidomide induces complete isotopic remission in Hodgkin's lymphoma relapsing after autologous stem cell transplantation.

Tempescul A, Ianotto JC, Eveillard JR, Guillerm G, Berthou C.

Ann Hematol. 2011 Aug;90(8):971-3. doi: 10.1007/s00277-010-1107-x. Epub 2010 Nov 6. No abstract available.

PMID:
21057951
19.

Acute dyspnoea and single tracheal localisation of mantle cell lymphoma.

Ianotto JC, Tempescul A, Eveillard JR, André N, Morel F, Quintin-Roué I, Berthou C.

J Hematol Oncol. 2010 Sep 28;3:34. doi: 10.1186/1756-8722-3-34.

20.

Non-lethal bone marrow necrosis under first-line arsenic trioxide therapy in acute promyelocytic leukaemia.

Ianotto JC, Tempescul A, Eveillard JR, Charles F, Berthou C.

Acta Haematol. 2010;123(3):146-7. doi: 10.1159/000281063. Epub 2010 Feb 5. No abstract available.

PMID:
20134156
21.

A possible relationship of lupus anti-coagulant with disease activity in Hodgkin lymphoma.

Ianotto JC, Tempescul A, Eveillard JR, Malou M, Berthou C.

Leuk Lymphoma. 2009 Jan;50(1):122-3. doi: 10.1080/10428190802517757. No abstract available.

PMID:
19152175
22.

Tri-lineage disease involving sideroblastic anaemia, multiple myeloma and B-cell non-Hodgkin's lymphoma in the same patient.

Ianotto JC, Tempescul A, Eveillard JR, Marion V, Quintin-Roué I, Berthou C.

Ann Hematol. 2009 Mar;88(3):273-4. doi: 10.1007/s00277-008-0586-5. Epub 2008 Aug 22. No abstract available.

PMID:
18719917
23.

High-dose melphalan followed by a second bone marrow transplantation in early relapse of acute myeloid leukemia after bone marrow transplantation in children.

Tempescul A, Ianotto JC, Eveillard JR, Guillerm G, Berthou C, Marion V, De Braekeleer M.

Ann Hematol. 2008 Jun;87(6):503-4. doi: 10.1007/s00277-007-0432-1. Epub 2008 Jan 3. No abstract available.

PMID:
18172644
24.

Inhibitory effect of the substance P and its derivative on erythropoietin-independent growth of erythroid progenitors in polycythemia vera.

Le Gall C, Ianotto JC, Hardy E, Ugo V, Eveillard JR, Ngo-Sack F, Bourquard P, Morice P, Berthou C.

Leuk Res. 2008 May;32(5):743-54. Epub 2007 Nov 5.

PMID:
17980427
25.

Is the c-Cbl proto-oncogene involved in chronic lymphocytic leukemia?

Mankaï A, Eveillard JR, Buhé V, Le Ster K, Loisel S, Ghedira I, Youinou P, Berthou C, Bordron A.

Ann N Y Acad Sci. 2007 Jun;1107:193-205.

PMID:
17804547
26.

[Disseminated cutaneous and visceral fusariosis in an aplastic patient: an unusual digestive entry].

Karam A, Eveillard JR, Ianoto JC, Quinio D, Le Flohic AM, Le Roy JP, Misery L, Berthou C.

Ann Dermatol Venereol. 2005 Mar;132(3):255-8. French.

PMID:
15924050
27.

[Subcutaneous mycosis due to Scopulariopsis brevicaulis in an aplasic patient].

Karam A, Hery G, Eveillard JR, Leroy JP, Leflohic AM, Sassolas B, Misery L, Berthou C.

Ann Dermatol Venereol. 2003 Aug-Sep;130(8-9 Pt 1):783-6. Review. French.

PMID:
14576610
28.

Ulceration of the penis due to Absidia corymbifera.

Karam A, Ianotto JC, Metges JP, Eveillard JR, Leroy JP, Le Flohic AM, Berthou C.

Br J Dermatol. 2003 Jun;148(6):1286-7. No abstract available.

PMID:
12828777

Supplemental Content

Loading ...
Support Center